0001104659-22-020560.txt : 20220211
0001104659-22-020560.hdr.sgml : 20220211
20220211163107
ACCESSION NUMBER: 0001104659-22-020560
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220210
FILED AS OF DATE: 20220211
DATE AS OF CHANGE: 20220211
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Romano Sarah
CENTRAL INDEX KEY: 0001697536
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36672
FILM NUMBER: 22621658
MAIL ADDRESS:
STREET 1: 271 WAVERLY OAKS ROAD
CITY: WALTHAM
STATE: MA
ZIP: 02452
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: KIORA PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001372514
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1371 EAST 2100 SOUTH
STREET 2: SUITE 200
CITY: SALT LAKE CITY
STATE: UT
ZIP: 84105
BUSINESS PHONE: (781) 788-8869
MAIL ADDRESS:
STREET 1: 1371 EAST 2100 SOUTH
STREET 2: SUITE 200
CITY: SALT LAKE CITY
STATE: UT
ZIP: 84105
FORMER COMPANY:
FORMER CONFORMED NAME: EYEGATE PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20060811
4
1
tm226424-1_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2022-02-10
0
0001372514
KIORA PHARMACEUTICALS INC
KPRX
0001697536
Romano Sarah
C/O KIORA PHARMACEUTICALS, INC.
1371 E. 2100 SOUTH, SUITE 200
WALTHAM
MA
02452
0
1
0
0
Chief Financial Officer
Common Stock
2022-02-10
4
F
0
108
0.69
D
22746
D
Sale of shares to cover taxes due on restricted stock that vested on 02/01/2022.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.69 to $0.70, inclusive. The reporting person hereby undertakes to provide to Kiora Pharmaceuticals, Inc., any security holder of Kiora Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
/s/ Sarah Romano
2022-02-11